TY - JOUR
T1 - Post-test medical diagnostic accuracy measures
T2 - an innovative approach based on the area under F-scores curves
AU - Samawi, Hani
AU - Kersey, Jing
AU - Alsharman, Marwan
N1 - Publisher Copyright:
© 2025 Taylor & Francis Group, LLC.
PY - 2025/6/17
Y1 - 2025/6/17
N2 - Clinicians have increasingly turned to F-scores to gauge the accuracy of diagnostic tests. However, the dependency of F-scores on the prevalence of the underlying illness poses challenges, especially when prevalence varies across regions or populations, potentially leading to misdiagnoses. To address this issue, this article presents novel post-test diagnostic precision metrics for continuous tests or biomarkers. These metrics are based on the collective areas under the F-score curves across all conceivable prevalence values. Unlike traditional measures, the proposed metrics remain constant regardless of disease prevalence, enabling fair comparisons of different diagnostic tests and biomarkers’ abilities in rule-in, rule-out, and overall accuracy. The article also explores the relationship between the proposed metrics and other diagnostic accuracy measures. Numerical illustrations and a real-world breast cancer dataset exemplify the application of the proposed metrics.
AB - Clinicians have increasingly turned to F-scores to gauge the accuracy of diagnostic tests. However, the dependency of F-scores on the prevalence of the underlying illness poses challenges, especially when prevalence varies across regions or populations, potentially leading to misdiagnoses. To address this issue, this article presents novel post-test diagnostic precision metrics for continuous tests or biomarkers. These metrics are based on the collective areas under the F-score curves across all conceivable prevalence values. Unlike traditional measures, the proposed metrics remain constant regardless of disease prevalence, enabling fair comparisons of different diagnostic tests and biomarkers’ abilities in rule-in, rule-out, and overall accuracy. The article also explores the relationship between the proposed metrics and other diagnostic accuracy measures. Numerical illustrations and a real-world breast cancer dataset exemplify the application of the proposed metrics.
KW - Biomarkers
KW - F-scores
KW - ROC
KW - negative predictive value
KW - positive predictive value
KW - youden index
UR - https://www.scopus.com/pages/publications/105009524493
U2 - 10.1080/10543406.2025.2512989
DO - 10.1080/10543406.2025.2512989
M3 - Article
C2 - 40525470
AN - SCOPUS:105009524493
SN - 1054-3406
SP - 1
EP - 18
JO - Journal of Biopharmaceutical Statistics
JF - Journal of Biopharmaceutical Statistics
ER -